Friday, March 13, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

U.S. supreme court abortion reversal would be global ‘catastrophe’ for women

The probable demise of abortion as a federal right in the US will be a “catastrophe” for women in low and middle-income countries, with an emboldened anti-choice movement likely to raise renewed pressure on hard-won gains, doctors and activists have warned.

The leak this month of the US supreme court’s draft majority opinion, which argued that the 1973 ruling effectively legalising abortion had been “egregiously wrong from the start”, stunned and enraged many in America.

But those shock waves did not stop at the borders of the US, as pro-choice figures around the world – many in countries with restrictive abortion laws and high levels of social stigma around reproductive rights – warned that Justice Samuel Alito’s words would “send a really clear message” of inspiration to anti-choice groups.

Source: The Guardian

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

2027 Medicare Advantage & Part D Advance Notice

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!